June 21, 2022-APHIOS PHARMA LLC TO HOST WEBINAR ON THE SCIENCE AND TECHNOLOGY OF CANNABIS AS A MEDICINE

July 9, 2021- Biotechnology Brings Microgravity Down to Earth

May 4, 2021 – Oral Nanoparticle-Encapsulated Bryostatin-1 found Effective for Treating Cognitive Deficits in an Alzheimer’s Disease Mouse Models

March 30, 2021 – Aphios Granted US Patent for Novel, More Potent Bryoid to Treat Alzheimer’s diseases, HIV-1 Latency, Prostate Cancer, Glaucoma and Multiple Sclerosis

December 01, 2020 – Aphios Granted US Patent for Combination Therapeutic to Treat Neurodegenerative Diseases

November 18, 2020 – Aphios International Launches Crowdfunding for Groundbreaking CFI Technology for Convalescent Plasma

March 5, 2020 – Aphios Granted Hong Kong Patent for Compound to Treat Neurodegenerative Diseases, Virus Latency, Cancer

January 28, 2020 – Aphios Granted US Patent for Combination HIV Latency Nanotherapeutic Towards an HIV Cure

December 4, 2019 – Aphios Granted US Patent for Oral Administration of Bryostatin-1 Nanoparticles for Treatment of Neurodegenerative Diseases

November 13, 2019 – Aphios Granted US Patent for Vitamin D3 Analog Nanoparticles for the Treatment of Prostate Cancer and Other Diseases

November 6, 2019 – Aphios Developing Pathogen Inactivation Technology for Biologics, Human Plasma, Immunoglobulins, Viral Vaccines

October 15, 2019 – Aphios Granted Chinese Patent For Novel Bryostatin To Treat Alzheimer’s Disease, HIV-I, Cancer

May 13, 2019 – Aphios Granted Japanese Patent For Novel Bryostatins To Treat Alzheimer’s And Other Diseases

April 16, 2019 – Aphios Microgravity Bioscience Experiments On Pico Technology And Alzheimer’s Disease Scheduled For Launch On NG-11 To The International Space Station On April 17, 2019

March 26, 2019 – Aphios Granted European Patent For Novel Bryostatin to Treat Alzheimer’s Disease, HIV-1, And Cancers

September 26, 2018 – Aphios is Developing Pathogen Inactivation Technology for Human Plasma Units

September 17, 2018 – Aphios Pharma LLC Announces Reg. CF Private Placement Offering

July 06, 2018 – Aphios Pharma LLC to Develop FDA-Approved, Cannabis-Based Drug for Opioid Addiction and other CNS Disorders

June 19, 2018 – Aphios and LSU Health Shreveport Inventors Granted Patent to Improve Transplantation

June 05, 2018 – Aphios Granted United States Patent for Improved Delivery of Targeted siRNA Using Nanotechnology